{"disease":{"id":"atopic-dermatitis-unspecified","name":"atopic dermatitis unspecified"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06899204","title":"Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT05732454","title":"A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Pfizer","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}